• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The dual role of the immune system in the course of COVID-19. The fatal impact of the aging immune system.免疫系统在新冠病毒疾病过程中的双重作用。衰老免疫系统的致命影响。
Cent Eur J Immunol. 2021;46(1):1-9. doi: 10.5114/ceji.2021.105240. Epub 2021 Apr 18.
2
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?COVID-19 与个体遗传易感性/接受性:ACE1/ACE2 基因、免疫、炎症和凝血的作用。与男性的单个 X 染色体相比,女性的双 X 染色体是否对 SARS-CoV-2 具有保护作用?
Int J Mol Sci. 2020 May 14;21(10):3474. doi: 10.3390/ijms21103474.
3
Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?炎症衰老和凝血衰老是否在导致 COVID-19 老年人中严重炎症状态和致命性凝血障碍同时发生的条件中起作用?
Exp Gerontol. 2021 Aug;151:111423. doi: 10.1016/j.exger.2021.111423. Epub 2021 May 26.
4
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.涉及 RAS 介导的缓激肽风暴的 COVID-19 的机械模型和治疗干预。
Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.
5
Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.维生素 D 在调节与 COVID-19 相关的免疫反应和免疫病理学中的推测作用。
Virus Res. 2021 Jan 15;292:198235. doi: 10.1016/j.virusres.2020.198235. Epub 2020 Nov 21.
6
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.细胞因子风暴和I型干扰素反应在新冠病毒疾病发病机制中的关键决定因素
Clin Microbiol Rev. 2021 May 12;34(3). doi: 10.1128/CMR.00299-20. Print 2021 Jun 16.
7
Aging in COVID-19: Vulnerability, immunity and intervention.COVID-19 相关衰老问题:脆弱性、免疫与干预。
Ageing Res Rev. 2021 Jan;65:101205. doi: 10.1016/j.arr.2020.101205. Epub 2020 Oct 31.
8
TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis.TGF-β1 通过 miRNA 抑制 ACE2 揭示了 SARS-CoV-2 发病机制的新机制。
J Innate Immun. 2023;15(1):629-646. doi: 10.1159/000533606. Epub 2023 Aug 14.
9
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.免疫反应随衰老而重塑:免疫衰老及其对 COVID-19 免疫反应的潜在影响。
Front Immunol. 2020 Aug 7;11:1748. doi: 10.3389/fimmu.2020.01748. eCollection 2020.
10
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.

引用本文的文献

1
Immunomodulatory Effects of RAAS Inhibitors: Beyond Hypertension and Heart Failure.肾素-血管紧张素-醛固酮系统抑制剂的免疫调节作用:超越高血压和心力衰竭
Biomedicines. 2025 Jul 21;13(7):1779. doi: 10.3390/biomedicines13071779.
2
Emergence of SARS-CoV-2 Variants Are Induced by Coinfections With Dengue.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的出现是由登革热合并感染引起的。
Bioinform Biol Insights. 2024 Sep 11;18:11779322241272399. doi: 10.1177/11779322241272399. eCollection 2024.
3
Association of human leukocyte antigen class II alleles with epithelial cell apoptosis and extracellular matrix production in acute COVID-19.人类白细胞抗原II类等位基因与急性新冠肺炎中上皮细胞凋亡及细胞外基质产生的关联
Cent Eur J Immunol. 2023;48(4):322-329. doi: 10.5114/ceji.2023.133684. Epub 2023 Dec 12.
4
Comparison of plasma mitochondrial DNA copy number in asymptomatic and symptomatic COVID-19 patients.无症状和有症状新冠肺炎患者血浆线粒体DNA拷贝数的比较
Front Microbiol. 2023 Oct 6;14:1256042. doi: 10.3389/fmicb.2023.1256042. eCollection 2023.
5
Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S.用亚致死剂量的中东呼吸综合征冠状病毒(MERS-CoV)或痘病毒载体中东呼吸综合征冠状病毒刺突蛋白(VRP-MERS-S)对感染新型冠状病毒(MERS-CoV-2)的小鼠进行免疫接种。
STAR Protoc. 2023 Feb 27;4(2):102171. doi: 10.1016/j.xpro.2023.102171.
6
The analysis of Fe-dependent serum enzymes in severe COVID-19 with a pulmonary thrombotic event.伴有肺血栓形成事件的重症新型冠状病毒肺炎中与铁相关的血清酶分析。
Cent Eur J Immunol. 2022;47(4):293-298. doi: 10.5114/ceji.2022.124076. Epub 2023 Jan 13.
7
Validation of the test for detecting SARS--CoV-2 antigens in the Polish population in patients with suspected SARS-CoV-2 infection.在波兰疑似感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的人群中检测SARS-CoV-2抗原检测试验的验证
Cent Eur J Immunol. 2022;47(1):58-62. doi: 10.5114/ceji.2022.113992. Epub 2022 Feb 28.
8
A Natural Plant Source-Tea Polyphenols, a Potential Drug for Improving Immunity and Combating Virus.天然植物源——茶多酚,一种提高免疫力和抗病毒的潜在药物。
Nutrients. 2022 Jan 27;14(3):550. doi: 10.3390/nu14030550.
9
Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs-Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.常用抗高血压药物-血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的免疫调节活性。
Int J Mol Sci. 2022 Feb 4;23(3):1772. doi: 10.3390/ijms23031772.
10
Estimation of viral kinetics model parameters in young and aged SARS-CoV-2 infected macaques.年轻和老年感染SARS-CoV-2猕猴的病毒动力学模型参数估计
R Soc Open Sci. 2021 Nov 17;8(11):202345. doi: 10.1098/rsos.202345. eCollection 2021 Nov.

本文引用的文献

1
Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.血浆中的病毒 RNA 载量与 COVID-19 中的危重病和宿主反应失调有关。
Crit Care. 2020 Dec 14;24(1):691. doi: 10.1186/s13054-020-03398-0.
2
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.SARS-CoV-2 的传播和发病机制。
Trends Immunol. 2020 Dec;41(12):1100-1115. doi: 10.1016/j.it.2020.10.004. Epub 2020 Oct 14.
3
Neuropilin-1 is a host factor for SARS-CoV-2 infection.神经纤毛蛋白 1 是 SARS-CoV-2 感染的宿主因子。
Science. 2020 Nov 13;370(6518):861-865. doi: 10.1126/science.abd3072. Epub 2020 Oct 20.
4
Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease.血管紧张素转换酶 2 及其与 SARS-CoV-2 疾病关联的 20 年研究进展。
Clin Sci (Lond). 2020 Oct 16;134(19):2645-2664. doi: 10.1042/CS20200901.
5
Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes.患有肺囊性纤维化的患者发生重症和致命性 COVID-19 的风险是否更高?白细胞介素 6 作为 COVID-19 预后的预测指标。
Pol Arch Intern Med. 2020 Oct 29;130(10):919-920. doi: 10.20452/pamw.15630. Epub 2020 Oct 5.
6
Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis.血浆 ACE2 与死亡或心血管代谢疾病风险:病例队列分析。
Lancet. 2020 Oct 3;396(10256):968-976. doi: 10.1016/S0140-6736(20)31964-4.
7
Immunosenescence is both functional/adaptive and dysfunctional/maladaptive.免疫衰老既有功能性/适应性的一面,也有功能失调/适应不良的一面。
Semin Immunopathol. 2020 Oct;42(5):521-536. doi: 10.1007/s00281-020-00818-9. Epub 2020 Sep 15.
8
Antibody-dependent enhancement of coronavirus.抗体依赖性增强冠状病毒感染。
Int J Infect Dis. 2020 Nov;100:483-489. doi: 10.1016/j.ijid.2020.09.015. Epub 2020 Sep 11.
9
COVID-19 herd immunity: where are we?COVID-19 群体免疫:我们在哪里?
Nat Rev Immunol. 2020 Oct;20(10):583-584. doi: 10.1038/s41577-020-00451-5.
10
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.抗体依赖性增强作用与 SARS-CoV-2 疫苗和疗法。
Nat Microbiol. 2020 Oct;5(10):1185-1191. doi: 10.1038/s41564-020-00789-5. Epub 2020 Sep 9.

免疫系统在新冠病毒疾病过程中的双重作用。衰老免疫系统的致命影响。

The dual role of the immune system in the course of COVID-19. The fatal impact of the aging immune system.

作者信息

Marcinkiewicz Janusz, Witkowski Jacek M, Olszanecki Rafał

机构信息

Chair of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.

Department of Pathophysiology, Medical University of Gdańsk, Poland.

出版信息

Cent Eur J Immunol. 2021;46(1):1-9. doi: 10.5114/ceji.2021.105240. Epub 2021 Apr 18.

DOI:10.5114/ceji.2021.105240
PMID:33897278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8056340/
Abstract

COVID-19 is a highly contagious respiratory disease caused by the novel coronavirus SARS-CoV-2. Since October 2020 the second wave of the pandemic has been observed around the world, as pathogen specific herd immunity has not been built yet. Moreover, the current, more contagious pathogen carrying the D614G mutation has become the globally dominant form of SARS-CoV-2. In this article we present the current state of knowledge on the impact of ACE2 and the reninangiotensin system (RAS) and the innate immune system on different outcomes of COVID-19. Especially, we point out the dual role of the immune system and ACE2 in pathogenesis of the disease. Namely, at the initial stage of the infection anti-viral activity of innate immunity is responsible for inhibition of SARS-CoV-2 replication. On the other hand, a dysregulated immune response may cause the detrimental hyperinflammation ("cytokine storm") responsible for the severe course of the disease. Concomitantly, we analyse the roles of ACE2 in both facilitation of infection and abrogation of its effects, as the major cellular entry receptor for SARS-CoV-2 and an important enzyme responsible for tissue protection, respectively. Finally, we discuss the dominant impact of aging on the fatal outcome of COVID-19.

摘要

COVID-19是一种由新型冠状病毒SARS-CoV-2引起的高传染性呼吸道疾病。自2020年10月以来,全球观察到第二波疫情,因为尚未建立针对病原体的群体免疫。此外,目前携带D614G突变的更具传染性的病原体已成为SARS-CoV-2在全球的主要形式。在本文中,我们介绍了关于血管紧张素转换酶2(ACE2)、肾素-血管紧张素系统(RAS)和先天免疫系统对COVID-19不同结局影响的当前知识状态。特别是,我们指出了免疫系统和ACE2在该疾病发病机制中的双重作用。也就是说,在感染初期,先天免疫的抗病毒活性负责抑制SARS-CoV-2复制。另一方面,失调的免疫反应可能会导致有害的过度炎症(“细胞因子风暴”),这是该疾病严重病程的原因。同时,我们分析了ACE2在促进感染和消除其影响方面的作用,ACE2分别作为SARS-CoV-2的主要细胞进入受体和负责组织保护的重要酶。最后,我们讨论了衰老对COVID-19致命结局的主要影响。